SPHK2 and cancer: RNA transcriptome microarray technology was used to understand the effects of SphK knockdown. RAS, MAPK, GTPase, Wnt, and PI3K were some of the pathways which were upregulated in the absence of SphK1 and SphK2, while other pathways involved in cancer were unaffected